IDEXX Laboratories, Inc.
Market Cap
$44.65B
P/E Ratio
42.91
EPS
$13.07
Dividend Yield
0.00%
52-Week Range
$462.05 — $769.98
Volume
708.39K
Avg Volume
533.71K
Beta
1.72
Get alerted when IDXX hits your target price.
Free — enter your email to get started
P/E (TTM)
42.91
Forward P/E
38.56
PEG Ratio
11.50
P/S (TTM)
10.42
P/B (TTM)
28.09
P/FCF
166.05
EV/EBITDA
171.36x
EV/Sales
—
ROE (TTM)
0.70%
ROA (TTM)
0.32%
ROIC
0.14%
Gross Margin
0.62%
Operating Margin
0.32%
Net Margin
0.23%
Debt/Equity
0.67
Current Ratio
1.17
EPS Growth (YoY)
+0.17%
Revenue Growth (YoY)
+0.17%
EPS Growth (3Y)
+0.18%
EPS Growth (5Y)
+0.15%
Sales Growth (3Y)
+0.09%
Sales Growth (5Y)
+0.10%
EPS Est (This Year)
$14.54
EPS Est (Next Year)
$16.45
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$2.25
Hold
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $784.38(39.9% upside)
Institutional %
61.49%
Inst. Net Change
7.66M
Insider Net Shares (90d)
-6835
Outstanding Shares
79.85M
Float
78.97M
Free Float %
98.90%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
1991-06-21
Employees
11000
CEO
Jonathan J. Mazelsky
Index Membership
S&P 500
Website
https://www.idexx.com
IDEXX Laboratories, Inc. (IDXX) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $44.65B, a P/E ratio of 42.91, IDXX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IDXX against other stocks using dozens of fundamental and technical filters.
IDEXX Laboratories, Inc. (IDXX) has a trailing twelve-month (TTM) P/E ratio of 42.91. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, IDEXX Laboratories, Inc. (IDXX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $44.65 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Hold" rating on IDEXX Laboratories, Inc. (IDXX) with an average score of 3.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $784.38 implies 39.9% upside from the current price.